The global cancer biomarkers market has experienced substantial growth over the last couple of years. This market is expected to grow at a CAGR of 11.6% from 2015 to 2020. Factors such as rising incidence of cancer; technological advancements in omics technologies; favorable government funding for cancer research; increased demand for personalized medicines in cancer therapies; and increased use of biomarkers in drug discovery development and clinical trials are expected to fuel the growth of the cancer biomarkers market during the forecast period.
Complete report on cancer biomarkers market spread across 208 pages, profiling 10 companies and supported with 93 tables and 61 figures is now available at http://www.reportsnreports.com/reports/420487-cancer-biomarkers-market-by-tumor-breast-lung-prostate-type-protein-genetic-biomarkers-profiling-technology-proteomics-genomics-imaging-immunoassay-application-diagnostic-drug-discovery-prognostic-geography-global-forecast-to-2020.html
Cancer biomarkers are molecules secreted by a tumor or a specific response of the body to the presence of cancer. These are substances or processes that are indicative of the presence of cancers in the human body, and enhance the cancer detection and facilitate high-speed noninvasive diagnosis using genomics and proteomics tools. The identification of cancer biomarkers is important to detect the tumors in the body.
Global Cancer Biomarkers Market, by Tumor Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
These are used for diagnostics, drug discovery and development, prognostics, personalized medicine, and surrogate endpoints and are becoming an integral part of various industries such as pharmaceutical and clinical trial companies, due to their ability to reduce the time and cost of the drug discovery and development process and clinical trials.
Interested in this report, Get sample copy of this research now
The report provides qualitative insights on key market shares, growth rates, and market drivers for important subsegments. It maps the market sizes and growth rates of each segment and identifies segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the biomarkers market. The company profiles include the financial performances, product portfolios, and developments of each company, whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as acquisitions, agreements, collaborations & partnerships; new product launches; and other developments.
Click now for more Details, Quiries and Discount and Other Information on this study “Cancer Biomarkers Market by Tumor (Breast, Lung, Prostate), Type (Protein & Genetic Biomarkers), Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast to 2020” research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=420487 .
Related Market Reports:
"Radiology Information Systems Market by Type (Integrated, Standalone), Deployment Mode (Web based, On-Premise, Cloud-Based), End User (Hospitals, Office based Physicians, Emergency Healthcare Service Providers) and by Component - Global Trends & Forecast to 2019” research available at http://www.reportsnreports.com/reports/145494-biomarkers-market-discovery-technologies-applications-indications-global-trends-opportunities-forecasts-2013-2018.html
Explore more Research Reports at http://www.reportsnreports.com/market-research/biotechnology/ .
ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013